Hot issues
Take action!
Contact your legislators to stop fake online pharmacies and report social media drug sellers to the DEA
Follow us: Twitter | YouTube | Facebook | LinkedIn | Instagram
The state of Colorado submitted a revised application to the U.S. Food and Drug Administration to operation a Canadian drug importation plan in March. This blog post examines how the state’s application has changed over the years.
A March 12, 2025 memo said the state had paid more than $150,000 defending itself in a lawsuit Amgen had filed over plans to set an upper payment limit on its rheumatoid arthritis treatment, Enbrel.
Senator Jim Banks asked pointed questions about how FDA will stem the tide of semaglutide and tirzepatide coming from unknown facilities.
“Alternative funding programs” are shifting expensive prescription coverage to illegal drug importation schemes.
On March 14, the Partnership for Safe Medicines submitted comment on Customs and Border Protection’s proposed update to regulations around low-value, “de minimus” shipments.
A Texas man billed government programs millions for creams compounded by untrained teenagers. News about counterfeit medicine in six U.S. states.
FDA’s shutdown of GLP-1 compounding could lead to a new era of risk for U.S. patients.
Our podcast covers the latest in pharma crime and medicine safety.
Like your information on video? Subscribe to our YouTube playlist!
How is unapproved semaglutide and tirzapetide getting into the US?
Why should fake drugs overseas matter to me? Watch.
Click the images below to see more recent videos.